Tag: subdural haematoma
Combined embolisation-drainage approach could be “transformational” next step in endovascular cSDH...
The past 18 months have seen a radical shift in clinical evidence supporting the role of middle meningeal artery embolisation (MMAe) within subdural haematoma...
Borvo Medical gains US FDA 510(k) clearance for novel, minimally invasive...
Borvo Medical has announced US Food and Drug Administration (FDA) 510(k) clearance of the Borvo Endoport Vacuum-Assisted Collection (EVAC) system—an advanced alternative to traditional...
Recent breakthroughs in cSDH intervention may lead to “HERMES-style collaborative”
Following their initial presentation earlier this year, two randomised controlled trials (RCTs) indicating positive outcomes with middle meningeal artery (MMA) embolisation in chronic subdural...
ARISE I recommends multidisciplinary approach to managing brain aneurysms, chronic SDHs...
Three papers published in the journal Stroke have highlighted multidisciplinary care and global, collaborative efforts as “paramount” in the management of intracranial aneurysms, chronic...
Addition of MMA embolisation reduces haematoma recurrence or progression in MAGIC-MT...
The use of middle meningeal artery (MMA) embolisation alongside standard care has been deemed superior to standard care alone for patients with symptomatic, non-acute...
MMA embolisation plus surgery reduces risk of subdural haematoma recurrence in...
Middle meningeal artery (MMA) embolisation—the injection of a liquid embolic substance to block an artery feeding the brain’s dura—along with surgery for subacute or...
RapidAI receives US FDA clearance of AI module for detecting hemispheric...
RapidAI announced today that it has received US Food and Drug Administration (FDA) clearance for Rapid SDH, its artificial intelligence (AI)-powered module for the detection...
Craniotomy and decompressive craniectomy achieve similar outcomes in acute subdural haematoma
The two prevailing techniques used during surgical treatments of traumatic acute subdural haematomas (SDHs)—craniotomy and decompressive craniectomy—have demonstrated broadly similar efficacy outcomes in a...
IRRAflow system leads to favourable clinical outcomes versus passive drainage in...
IRRAS has announced the publication of the first comparative study detailing the use of the company's novel IRRAflow system. This study, which was conducted under the...
Viz.ai receives US FDA 510(k) clearance for Viz SDH, announces Hyperfine...
Viz.ai today announced it has received US Food and Drug Administration (FDA) 510(k) clearance for Viz Subdural (SDH). The Viz SDH algorithm uses artificial...
